The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of dabrafenib (D) and trametinib (T) in patients (pts) with BRAF V600E–mutated anaplastic thyroid cancer (ATC).
 
Vivek Subbiah
Research Funding - Novartis, GSK, Nanocarrier, NorthWest Biotherapeutics, Roche/Genentech, BergPharma, Bayer, Incyte, FujiFilm, Pharmamar, D3, Pfizer Amgen, Abbvie, Multivir, Bluprint Medicines.
Travel, Accommodations, Expenses - Novartis, Pharmamar, Fujifilm
 
Robert J. Kreitman
Research Funding - GlaxoSmithKline (Inst); Novartis (Inst)
 
Zev A. Wainberg
Consulting or Advisory Role - Amgen; Array BioPharma; Five Prime Therapeutics; Sirtex Medical
Speakers' Bureau - Genentech
Research Funding - Biomarin (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Plexxikon (Inst)
Travel, Accommodations, Expenses - Amgen; Genentech
 
Jae Yong Cho
No Relationships to Disclose
 
Jan H.M. Schellens
No Relationships to Disclose
 
Jean-Charles Soria
Honoraria - Novartis
 
Patrick Y. Wen
Consulting or Advisory Role - Cavion; Cortice Biosciences; Foundation Medicine; Genentech/Roche; Insys Therapeutics; Monteris Medical; Novartis; Vascular Biogenics
Speakers' Bureau - Merck
Research Funding - Acerta Pharma; Agios; Angiochem; AstraZeneca; Genentech/Roche; GlaxoSmithKline; Karyopharm Therapeutics; Merck; Novartis; Oncoceutics; Sanofi; Vascular Biogenics
 
Christoph Zielinski
Honoraria - Novartis
Consulting or Advisory Role - Novartis
 
Gladys Urbanowitz
Employment - Novartis
Stock and Other Ownership Interests - Novartis
Research Funding - Novartis
 
Bijoyesh Mookerjee
Employment - GlaxoSmithKline; Novartis
Stock and Other Ownership Interests - AstraZeneca; GlaxoSmithKline; Incyte; Novartis
 
Dazhe Wang
Employment - Novartis; Novartis (I)
Stock and Other Ownership Interests - Novartis; Novartis (I)
 
Fatima A. Rangwala
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Bhumsuk Keam
No Relationships to Disclose